FDA-Drug2026-08-26Class IIPROCESSING DEFECT
Golden State Medical Supply Carbamazepine 200mg tablets recalled for black specks
What this means
Golden State Medical Supply is recalling Carbamazepine Tablets, USP 200mg due to black specks found in some tablets. This is a manufacturing quality issue. The affected lots were distributed nationwide.
- Check if you have one of the affected lot numbers: GS067429, GS068091, GS067430, or GS068090 (all expiring 5/31/2028)
- Contact your pharmacist or doctor if you have this medication
- Do not stop taking your carbamazepine without medical advice; your doctor can help you get unaffected tablets
The agency's original wording
Hazard
CGMP deviations: tablets with black specks.
Intended for
Adults
Illnesses reported
None reported
Sold states
USA Nationwide
Affected count
1200 bottles
Manufactured in
5187 Camino Ruiz, Camarillo, CA, United States
Products
Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-215-01), Rx Only, Manufactured by: Taro Pharmaceutical Industries Ltd., Marketed by: GSMS, Incorporated, Camarillo, CA 93012 USA
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0771-2026More Golden State Medical Supply recalls
Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.